Acutaas Chemicals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
ACUTAAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Acutaas Chemicals (formerly Ami Organics) reported strong Q1 FY26 results. Consolidated revenue from operations rose ~17% YoY to ₹207.24 crore (vs ₹176.67 crore in Q1 FY25), while consolidated net profit surged nearly 3x to ₹44.01 crore (vs ₹14.69 crore). Standalone numbers were even stronger, with revenue up ~20% YoY to ₹205.97 crore and profit tripling to ₹44.65 crore. Basic EPS stood at ₹5.41 (consolidated) and ₹5.45 (standalone), reflecting the recent stock split from ₹10 to ₹5 face value. The company highlighted investments in subsidiary Acutaas Advance Material (up to ₹199.99 crore), a new South Korea JV (Indichem Inc. with J & Materials), and 100% utilization of the ₹99.10 crore preferential issue proceeds. The auditor's limited review report was clean with no modifications.
Sharp YoY profit growth of ~200% and healthy margin expansion signal strong operating momentum, likely to be viewed positively by investors. However, sequential QoQ decline (revenue down ~33% vs Q4 FY25) suggests some quarter-on-quarter volatility typical of the specialty chemicals business.